Digital Biomanufacturing Market Size, Scope, Forecast Report 2026 to 2035
What is Digital Biomanufacturing Market Size?
The Digital Biomanufacturing Market Size is valued at USD 25.82 Billion in 2025 and is predicted to reach USD 106.50 Billion by the year 2035 at a 15.8 % CAGR during the forecast period for 2026 to 2035.
Digital Biomanufacturing Market Size, Share & Trends Analysis Report By Application (Biomanufacturing Process Automation and Control, Bioprocess Optimization and Process Analytics, Flexible Manufacturing), By Technology, Deployment option, By End-User, Region And Segment Forecasts, 2026 to 2035.
Digital Biomanufacturing Market Key Takeaways:
|
Key Industry Insights & Findings from the Report:
- There is a growing demand for biologics, including vaccines, monoclonal antibodies, and gene therapies. Digital biomanufacturing optimizes production processes to meet this demand more cost-effectively and sustainably.
- These technologies enhance data collection, monitoring, process control, and automation, leading to more efficient and scalable production processes
- North America dominated the market and accounted for a global revenue share in 2023.
The biopharmaceutical industry's tremendous expansion has brought about new opportunities for patient care and difficulties in production. Numerous cutting-edge medical techniques make use of speciality medications that are designed to treat limited patient populations, and this indicates that substantially less drug production occurs. Manufacturers must therefore increase their operational effectiveness to lower total drug development and production costs in order to satisfy the public's need for affordable access to new medications. The Industry 4.0 paradigm will assist in achieving this objective. Using digital technologies in manufacturing processes, such as computer-aided design and computer-assisted machining, is known as "digital biomanufacturing." By enhancing manufacturing cycles, the use of these technologies can assist raise quality and safety requirements while also lowering costs. With robotic automation systems like microfluidic devices, digital biomanufacturing enables increased precision in cell cultures or tissue engineering. It also makes it possible to remotely monitor individual units using embedded sensors that transmit data back to operators via wireless networks, enabling more effective management of inventory levels during manufacturing.
Competitive Landscape
Some of The Key Players in The Digital Biomanufacturing Market:
- Agilent Technologies Inc.
- Danaher Corporation
- Donaldson Company, Inc.
- Emerson Electric Co.
- General Electric Company
- Honeywell International Inc.
- SAP SE
- Siemens Healthineers AG
- Bota Biosciences
- Culture Biosciences
- e-matica srl
- Exponential Genomics, Inc. (Xenomics)
- FabricNano
- OVO Biomanufacturing
- Symphony Innovation, LLC
- Other Prominent Players
Market Segmentation:
The digital biomanufacturing market is segmented on the basis of application, end-user, deployment option and technology. Based on application, the market is segmented as Biomanufacturing Process Automation and Control, Bioprocess Optimization and Process Analytics, and Flexible Manufacturing. By end-user, the market is segmented into Biopharmaceutical Companies and Academic and Research Institutes. As per the Deployment Option, the market is categorized into Cloud-based and On-premises. Technology segments the market into AI and IoMT Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics and Digital Twin Technologies, and Others.
Based on product, the bioprocess optimization and process analytics segment are accounted as a major contributor in the digital biomanufacturing market.
Digital biomanufacturing is utilized in process analytics and bioprocess optimization to track, enhance, and manage bioprocesses. By processing algorithms on a computer to be tuned for the process before being moved to an industrial system where it can run automatically without human involvement, it helps. As a result of these systems' greater accuracy and ability to decrease errors made during manual operation processes, activities become more efficient. These features are driving the bioprocess optimization and process analytics segment in the market.
AI and IoMT solutions segment witness growth at a rapid rate
The Internet of Medical Things (IoMT) was formed as a result of the increase in linked medical devices, improvements in the hardware and software that enable the collection and transfer of medical-grade data, and connectivity technologies and services. The IoMT integrates the physical and digital worlds to enhance diagnostic and treatment speed and accuracy as well as to track and adjust patient behaviour and health status in real-time. Streamlining clinical processes, information, and workflows also raises the operational productivity and effectiveness of healthcare organizations. An increasing geriatric population, with more people living longer but with many comorbidities, is partly responsible for the increase of AI and IoMT solutions.
The North America Digital Biomanufacturing market holds a significant revenue share in the region.
North America has the largest revenue share owing to its sophisticated healthcare system and substantial demand for biologics. North American businesses are increasingly opting to digitize their biologics. Furthermore, industrial organizations are investing a lot in digital technology and related assets to improve production efficiency and lower operating costs. Governments in the area are sponsoring research and development programmes to set up cutting-edge sensor networks, process controls, and data analytics in industrial firms to boost productivity and energy efficiency. Canadian manufacturers are investing in the conversion of physical factories into digital factories. They are largely concentrating on supply chain collaboration, automation and robotics, and intelligent floor sensors. As a result, the Canadian market is anticipated to display an extraordinary CAGR over the forecast period.
Recent Developments:
- In April 2024, SAP SE revealed artificial intelligence (AI) enhancements in its supply chain solutions that will bring about major improvements in productivity, efficiency, and accuracy in the manufacturing industry. Utilizing AI-powered analysis of up-to-the-minute data, firms may leverage their own data to enhance decision-making throughout supply chains, optimize product creation, and enhance industrial efficiency.
The Digital Biomanufacturing Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 25.82 Billion |
| Revenue Forecast In 2035 | USD 106.50 Billion |
| Growth Rate CAGR | CAGR of 15.8 % from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Billion and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2024 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Technology, By Application, By End-User, Deployment option |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Agilent Technologies Inc., Danaher Corporation, Donaldson Company, Inc., Emerson Electric Co., General Electric Company, Honeywell International Inc., SAP SE, Siemens Healthineers AG, Bota Biosciences, Culture Biosciences, e-matica srl, Exponential Genomics, Inc. (Xenomics), FabricNano, OVO Biomanufacturing, Symphony Innovation, LLC, Other Prominent Players |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Digital Biomanufacturing Market-
By Application -
- Biomanufacturing Process Automation and Control
- Bioprocess Optimization and Process Analytics
- Flexible Manufacturing
By End-user-
- Biopharmaceutical Companies
- Academic and Research Institutes
By Deployment Option-
- Cloud-based
- On-premises
By Technology-
- AI and IoMT Solutions
- Process Analytical Technologies
- Data Analytics Software
- Predictive Analytics and Digital Twin Technologies
- Others
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
General Electric Company, Honeywell International Inc., SAP SE, Siemens Healthineers AG, Bota Biosciences, Culture Biosciences, e-matica srl, Exponent
Digital Biomanufacturing Market Size is valued at 25.82 Billion in 2025 and is predicted to reach 106.50 Billion by the year 2035.
The Digital Biomanufacturing Market is expected to grow at a 15.8 % CAGR during the forecast period for 2026-2035.
Digital biomanufacturing market is segmented on the basis of application, end-user, deployment option and technology.
North American region is leading the Digital biomanufacturing market.